T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Cavco Industries
CVCO
$4.67B
| $38.5M | 0.01% |
111,079
+488
| +0.4% | +$139K |
|
777
Royalty Pharma
RPRX
$26.1B
| $38.4M | 0.01% |
1,368,154
-622,848
| -31% | -$17.1M |
|
778
AMN Healthcare
AMN
$1.34B
| $38.4M | 0.01% |
512,387
-133,896
| -21% | -$9.58M |
|
779
Leonardo DRS
DRS
$11.9B
| $37.9M | 0.01% |
1,890,159
+299,275
| +19% | +$5.65M |
|
780
Champion Homes
SKY
$5.23B
| $37.7M | 0.01% |
507,938
+13,453
| +3% | +$846K |
|
781
Edison International
EIX
$27.2B
| $37.2M | 0.01% |
520,364
+9,756
| +2% | +$641K |
|
782
Brown & Brown
BRO
$24B
| $37.1M | 0.01% |
521,050
+137,052
| +36% | +$9.8M |
|
783
Xylem
XYL
$28.1B
| $37M | 0.01% |
323,764
+8,879
| +3% | +$886K |
|
784
Church & Dwight Co
CHD
$24B
| $37M | 0.01% |
390,833
+10,232
| +3% | +$936K |
|
785
Akamai
AKAM
$18B
| $36.9M | 0.01% |
311,440
+24,884
| +9% | +$2.77M |
|
786
Regions Financial
RF
$27B
| $36.8M | ﹤0.01% |
1,896,635
-412,873
| -18% | -$6.85M |
|
787
Synchrony
SYF
$26.1B
| $36.6M | ﹤0.01% |
957,597
+396,930
| +71% | +$12.6M |
|
788
State Street
STT
$52.2B
| $36.5M | ﹤0.01% |
470,623
-574,428
| -55% | -$40M |
|
789
Amphastar Pharmaceuticals
AMPH
$858M
| $36.3M | ﹤0.01% |
586,957
+17,245
| +3% | +$906K |
|
|
CTRA
790
DELISTED
Coterra Energy
CTRA
| $36.2M | ﹤0.01% |
1,419,928
+8,616
| +0.6% | +$231K |
|
791
Agios Pharmaceuticals
AGIO
$2B
| $36.2M | ﹤0.01% |
1,624,612
-1,498
| -0.1% | -$33.6K |
|
792
Willis Towers Watson
WTW
$31B
| $35.9M | ﹤0.01% |
148,855
-1,215
| -0.8% | -$281K |
|
793
Surgery Partners
SGRY
$1.99B
| $35.4M | ﹤0.01% |
1,107,671
-449,293
| -29% | -$13M |
|
794
HP
HPQ
$28.6B
| $35.4M | ﹤0.01% |
1,175,991
+12,812
| +1% | +$359K |
|
795
Atmus Filtration Technologies
ATMU
$4.06B
| $35.4M | ﹤0.01% |
1,505,418
+726,918
| +93% | +$15.6M |
|
796
Pacific Biosciences
PACB
$357M
| $35.3M | ﹤0.01% |
3,599,275
-389,435
| -10% | -$3.18M |
|
797
Flowserve
FLS
$10.3B
| $35.3M | ﹤0.01% |
855,919
+28,350
| +3% | +$1.09M |
|
798
Alcoa
AA
$13.1B
| $35.2M | ﹤0.01% |
1,034,031
+959,655
| +1,290% | +$26M |
|
799
Addus HomeCare
ADUS
$2.2B
| $35.1M | ﹤0.01% |
378,131
-1,475
| -0.4% | -$128K |
|
800
Asbury Automotive
ABG
$3.78B
| $34.9M | ﹤0.01% |
155,217
+25,718
| +20% | +$5.44M |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.